ARCHIVES

Fischinger Names Research VP at MUSC (Charleston); Meyskens Names Director Of New UC (Irvine Center)

This article is from The Cancer Letter archive.

Vol. 14 No. 42 | October 28, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Delays NDA On BCNU, But New Drug Seminar Still Scheduled

November 28, 1975

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

April 26, 2013

ACS Plans To Review Prostate Cancer Screening Guideline

March 20, 2009

DCBDC Advisors Set aside $2 Mil. For Research On The Microenvironment of Breast Cancer

July 9, 1993

Van Etten To Take Over As Director Of UC Irvine Chao Cancer Center

July 25, 2013

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

June 4, 2004